Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Inv. presentation
|
|
Eloxx Pharmaceuticals, Inc. (ELOX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2021 |
3
| PAREKH RAJESH B (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 04/02/2021 |
3
| MODUR VIJAY (HEAD OF R&D) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 04/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/02/2021 |
3
| Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 04/02/2021 |
3
| Walts Alan Edmund (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 03/26/2021 |
3
| Rakers Gary D. (Controller, PFO/PAO, Treasurer) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 01/22/2021 |
3
| MacDonald Stephen G. (VP Finance & Acctg, Treasurer) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 06/26/2018 |
3
| Williams Gregory C. (COO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 06/26/2018 |
3
| Snow David P. (Chief Business Officer) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 06/20/2018 |
3
| Belloff Neil S. (General Counsel and Secretary) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 03/05/2018 |
3
| Seehra Jasbir (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Nussbaum Ran (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Heft Robert (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Kleijwegt Martijn (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Kariv Tomer (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Avnur Zafrira (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Noiman Silvia (CEO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Huertas Pedro (Chief Medical Officer) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Veinrib Gadi (Director) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Pontifax Management III G.P. (2011) Ltd. (10% Owner) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
3
| Shabtai Gilad (10% Owner) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/28/2017 |
3
| Ward Robert (CEO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/22/2017 |
3
| WEAVER GREGORY L (CFO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 08/04/2017 |
3
| Opko Health, Inc. (10% Owner) has filed a Form 3 on Sevion Therapeutics, Inc. |
| 03/12/2012 |
3
| Klaver Paul Edward (10% Owner) has filed a Form 3 on SENESCO TECHNOLOGIES INC |
| 05/27/2010 |
3
| Browne Leslie J (President and CEO) has filed a Form 3 on SENESCO TECHNOLOGIES INC |
| 11/20/2009 |
3
| Partlet Holdings Ltd (10% Owner) has filed a Form 3 on SENESCO TECHNOLOGIES INC |
| 06/17/2009 |
3
| Isabelle Warren John (Director) has filed a Form 3 on SENESCO TECHNOLOGIES INC |
|
|